Trial of ferric carboxymaltose in heart failure does not meet primary endpoint
Ferric carboxymaltose (FCM) did not improve a hierarchical outcome of death, heart failure hospitalizations and exercise function in ambulatory patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency, ...
Aug 28, 2023
0
23